GLAXO.BO

GlaxoSmithKline Pharmaceuticals Limited

HealthcareDrug Manufacturers - GeneralININRPeers →Country macro →

$2,188.30

Jun 02, 2026

AI Brief

Market cap

—

52w range

—

P / E

—

EPS · FY 2026

$61.15

Volume

—

Revenue · FY 2026

$38.22B

Overview Profile Financials Ratios Multiples Valuation Factors Quant Themes Trend Thesis Committee Earnings Segments Prices Analysts Dividends Corp actions Sentiment ESG

Explain this page

Arphra AIPlain-English read on GlaxoSmithKline Pharmaceuticals Limited’s valuation

AI Issuer Brief

Arphra AI

Loading cached brief…

Price

DB · prices_daily

1M 6M 1Y 5Y

Last

$2188.30

Change

-9.11%

Period high

$2700.80

Period low

$2188.30

Period start

$2407.552026-02-01

Through 2026-06-02

Fair value

Football field →

Weighted blend

$1,360.84

— vs spot

Recommendation

n/a

3 of 3 methods

Method spread

0bull0bear

±5% threshold

Insider · 30d

History →

Bought

0 txns

Sold

0 txns

Net flow

+$0

Recent quarters

All financials →

Period	Revenue	Net income	EPS

Analyst view

Consensus target

—

No price-target data returned for this ticker.

Recent actions

0 ↑0 ↓0 hold

No recent grade actions.

News

DB · news_items

No recent news for GLAXO.BO.

Peers

No peer list available for GLAXO.BO.

Total assets

$43.24B

Total debt

$332.7M

Cash & equiv

$13.91B

Operating CF

$10.22B

Free cash flow

$9.67B

Buybacks

Recent insiders

All →

Insider	Action	Shares	Value	Date
No open-market insider activity in the recent window.

Income statement · annual

Open Financials →

Period	Revenue	Op income	Net income	EPS	Net margin
FY 2026	$38.22B	$12.43B	$10.36B	$61.15	+27.11%